Prothena | PRTA - الربح قبل الضريبة





الربح قبل الضريبة تغيير تاريخ
Acadia Pharmaceuticals USD 3.98M 22.34M 2026-03
Agios Pharmaceuticals USD -99.11M 9.94M 2026-03
Akebia Therapeutics USD -11.24M 12.39M 2025-12
ALKERMES USD -61.93M 122.3M 2026-03
Alnylam Pharmaceuticals USD 221.65M 60.52M 2026-03
Amgen USD 1.51B 2.41B 2025-12
Biogen USD 377.7M 433.7M 2026-03
BioMarin Pharmaceutical USD 141.2M 168.36M 2026-03
Exelixis USD 267.69M 15M 2026-03
Immunic USD -19.3M 6.28M 2025-12
Incyte USD 343.6M 46.34M 2026-03
Ionis Pharmaceuticals USD -93M 135M 2026-03
MacroGenics USD -36.77M 21.84M 2026-03
Nektar Therapeutics USD -34.7M 2.35M 2025-12
Neurocrine Biosciences USD 246.8M 7.4M 2026-03
Prothena USD 32.72M 54.3M 2026-03
Regeneron Pharmaceuticals USD 1.04B 719.6M 2025-12
Ultragenyx Pharmaceutical USD -184M 56M 2026-03
Vertex Pharmaceuticals USD 1.25B 78.1M 2026-03
Xoma USD 15.98M 24.58M 2024-06